Alpha Klotho

An anti-aging protein that has emerged as a critical mediator between heavy metal exposure and chronic kidney disease progression. Originally discovered as a gene whose mutation caused premature aging in mice, alpha-klotho is now understood to be a multifunctional protein with renal protective, antioxidant, and anti-inflammatory properties — and its suppression by toxic metals may be one of the key mechanisms through which low-dose environmental metal exposure translates into chronic kidney damage.

Biology

Expression and Forms

  • Primarily expressed in the kidney (distal convoluted tubule), with lower expression in brain choroid plexus and parathyroid glands
  • Exists in two forms:
  • Membrane-bound: Functions as a co-receptor for fibroblast growth factor 23 (FGF23), regulating phosphate and calcium homeostasis
  • Soluble (secreted/cleaved): Circulates in blood and CSF; acts as an endocrine factor with pleiotropic protective effects

Protective Functions

Alpha-klotho exerts renal and systemic protection through multiple mechanisms [1]:

  • Antioxidant enzyme regulation: Upregulates superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase 4 (GPX-4) — the same enzyme whose loss triggers ferroptosis
  • TLR4 signaling suppression: Inhibits toll-like receptor 4 activation, reducing innate immune inflammatory cascades
  • NF-kappaB inhibition: Blocks the master inflammatory transcription factor, reducing pro-inflammatory cytokine production
  • Autophagy promotion: Facilitates cellular cleanup of damaged organelles and protein aggregates
  • Calcium/vitamin D homeostasis: Regulates mineral metabolism through FGF23 co-receptor function

The Metal-Klotho-CKD Axis

A machine learning analysis of 51 pollutants identified heavy metals (cadmium, thallium, lead, mercury) as the most impactful on CKD risk [1]. Alpha-klotho sits at the center of this relationship:

Mediation Evidence

  • Alpha-klotho mediates 34.55% of the mercury-CKD association
  • Mendelian randomization confirmed directionality: higher alpha-klotho levels causally reduce CKD risk (OR 0.9842, using 6 genetic instruments)
  • Alpha-klotho levels are significantly lower in CKD patients (727.65 vs 798.80 pg/mL, p < 0.0001)

Proposed Mechanism

The working model: toxic metals suppress alpha-klotho expression in renal tubular cells, which:

  1. Reduces antioxidant defenses (SOD, CAT, GPX-4 decline)
  2. Permits oxidative stress accumulation in kidney tissue
  3. Increases inflammatory signaling (NF-kappaB, TLR4 derepressed)
  4. Impairs autophagy, allowing damaged cell components to accumulate
  5. Progressive tubular injury leads to CKD

This creates a vulnerability loop: as kidney function declines, metal clearance is impaired, further suppressing alpha-klotho, accelerating decline.

CKD Context

Alpha-klotho decline is one of the earliest detectable changes in CKD progression, occurring before significant GFR reduction [2]:

  • Cadmium specifically targets proximal tubular cells, where it accumulates bound to metallothionein; lysosomal degradation releases free Cd, suppressing klotho
  • Mercury and lead contribute to tubular injury through oxidative mechanisms
  • Thallium had the highest posterior inclusion probability (PIP = 1.0) in BKMR models, suggesting it may be particularly potent in suppressing klotho pathways

Microbiome Relevance

The alpha-klotho axis connects to the gut microbiome through several mechanisms:

  • CKD-associated dysbiosis produces uremic toxins (including p cresol and indoxyl sulfate) that further suppress klotho expression
  • Gut-brain-axis signaling may modulate central alpha-klotho expression in the choroid plexus
  • Intestinal inflammation from dysbiosis increases systemic metal absorption, potentially accelerating klotho suppression

<!— NEEDS VERIFICATION: Direct studies of gut microbiome effects on alpha-klotho expression are limited —>

Open Questions

  1. Do other metals beyond Cd, Hg, Pb, and Tl suppress alpha-klotho? The CKD signatures in this wiki include nickel and arsenic as co-elevated metals
  2. Can klotho-enhancing interventions (e.g., soluble klotho supplementation) protect against metal-induced nephrotoxicity?
  3. Does the gut microbiome modulate alpha-klotho expression through metabolite signaling?

Connections

  • chronic kidney disease — alpha-klotho decline is an early CKD biomarker
  • thallium — highest inclusion probability for CKD risk in BKMR models
  • cadmium — proximal tubular accumulation suppresses klotho
  • oxidative stress — klotho loss derepresses ROS generation
  • ferroptosis — klotho upregulates GPX-4, the ferroptosis brake
  • nf kappa b — klotho inhibits this master inflammatory regulator
  • metallothionein — Cd-MT complexes in renal tubules release free Cd that suppresses klotho

References (3)

  1. Liu S, Wang H, Cao Y et al. (2025). The association between low-concentration heavy metal exposure and chronic kidney disease risk through alpha-klotho. Scientific Reports. doi:10.1038/s44439-024-00009-w
  2. ★Manish Mishra, Larry Nichols, Aditi A. Dave et al. (2022). Molecular Mechanisms of Cellular Injury and Role of Toxic Heavy Metals in Chronic Kidney Disease. International Journal of Molecular Sciences. doi:10.3390/ijms23063997
  3. Di Ciaula A, Garruti G, Lunardi Baccetto R et al. (2017). Bile acid physiology. Annals of Hepatology. doi:10.5604/01.3001.0010.5493

Related Articles